Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 3, 2010, Pages 743-750

  Fuchsjäger, Michael H ^a   Pucar, Darko ^a   Zelefsky, Michael J ^a   Zhang, Zhigang ^a   Mo, Qianxing ^a   Ben Porat, Leah S ^a   Shukla Dave, Amita ^a   Wang, Liang ^a   Reuter, Victor E ^a   Hricak, Hedvig ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Biochemical recurrence; External beam radiation therapy; Extracapsular extension; MRI; Prostate cancer

Indexed keywords

BIOCHEMICAL RECURRENCE; EXTERNAL BEAM RADIATION THERAPY; EXTRACAPSULAR EXTENSION; MRI; PROSTATE CANCERS;

DISEASES; FORECASTING; MULTIVARIANT ANALYSIS; RADIOTHERAPY; RESONANCE;

MAGNETIC RESONANCE IMAGING;

ANTINEOPLASTIC AGENT; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIOLOGIST; TREATMENT OUTCOME; TUMOR VOLUME; ADJUVANT THERAPY; BLOOD; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; TIME; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; TIME FACTORS; TUMOR BURDEN;

EID: 77957200095     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.08.040     Document Type: Article

References (40)

1. M.W. Kattan, J.A. Eastham, and A.M. Stapleton A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90 1998 766 771
2. M.W. Kattan, M.J. Zelefsky, and P.A. Kupelian Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer J Clin Oncol 18 2000 3352 3359
3. R.W. Ross, and P.W. Kantoff Predicting outcomes in prostate cancer: How many more nomograms do we need? J Clin Oncol 25 2007 3563 3564
4. A.J. Stephenson, P.T. Scardino, and J.A. Eastham Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Natl Cancer Inst 98 2006 715 717
5. M.J. Zelefsky, M.W. Kattan, and P. Fearn Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer Urology 70 2007 283 287
6. A.V. D'Amico, R. Whittington, and B. Malkowicz Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer J Urol 164 2000 759 763 (Pubitemid 30637618)
7. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer Urology 55 2000 572 577
8. M.H. Fuchsjäger, A. Shukla-Dave, and H. Hricak Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy BJU Int 104 2009 315 320
9. T. Joseph, D.A. McKenna, and A.C. Westphalen Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy Int J Radiat Oncol Biol Phys 73 2009 665 671
10. D.A. McKenna, F.V. Coakley, and A.C. Westphalen Prostate cancer: Role of pretreatment MR in predicting outcome after external-beam radiation therapy - Initial experience Radiology 247 2008 141 146
11. P.L. Nguyen, R. Whittington, and S. Koo Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer Int J Radiat Oncol Biol Phys 59 2004 400 405
12. D. Pucar, J.A. Koutcher, and A. Shah Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse Clin Prostate Cancer 3 2004 174 181
13. A. Shukla-Dave, H. Hricak, and M.W. Kattan The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: An initial analysis BJU Int 99 2007 786 793
14. C. Bartolozzi, I. Menchi, and R. Lencioni Local staging of prostate carcinoma with endorectal coil MRI: Correlation with whole-mount radical prostatectomy specimens Eur Radiol 6 1996 339 345
15. A. Graser, A. Heuck, and B. Sommer Per-sextant localization and staging of prostate cancer: Correlation of imaging findings with whole-mount step section histopathology AJR Am J Roentgenol 188 2007 84 90
16. M. Mullerad, H. Hricak, and K. Kuroiwa Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer J Urol 174 2005 2158 2163
17. K.K. Yu, H. Hricak, and R. Alagappan Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: Multivariate feature analysis Radiology 202 1997 697 702
18. K.K. Yu, J. Scheidler, and H. Hricak Prostate cancer: Prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging Radiology 213 1999 481 488
19. M.R. Engelbrecht, G.J. Jager, and R.J. Laheij Local staging of prostate cancer using magnetic resonance imaging: A meta-analysis Eur Radiol 12 2002 2294 2302
20. M. Mullerad, H. Hricak, and L. Wang Prostate cancer: Detection of extracapsular extension by genitourinary and general body radiologists at MR imaging Radiology 232 2004 140 146
21. E. Sala, O. Akin, and C.S. Moskowitz Endorectal MR imaging in the evaluation of seminal vesicle invasion: Diagnostic accuracy and multivariate feature analysis Radiology 238 2006 929 937
22. L. Wang, M. Mullerad, and H.N. Chen Prostate cancer: Incremental value of endorectal MR imaging findings for prediction of extracapsular extension Radiology 232 2004 133 139
23. L. Wang, H. Hricak, and M.W. Kattan Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer AJR Am J Roentgenol 186 2006 743 748
24. L. Wang, J. Zhang, and L.H. Schwartz Prediction of seminal vesicle invasion in prostate cancer: Incremental value of adding endorectal MR imaging to the Kattan nomogram Radiology 242 2007 182 188
25. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials J Clin Oncol 18 2000 3240 3246
26. C. Burman, C.S. Chui, and G. Kutcher Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate Int J Radiat Oncol Biol Phys 39 1997 863 873
27. M. Roach III, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
28. J.J. Bauer, R.R. Connelly, and I.A. Sesterhenn Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy Cancer 79 1997 952 962
29. J.W. Moul, R.R. Connelly, and D.P. Lubeck Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases J Urol 166 2001 1322 1327
30. S.J. Freedland, E.B. Humphreys, and L.A. Mangold Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 294 2005 433 439
31. A.W. Partin, M.W. Kattan, and E.N. Subong Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 277 1997 1445 1451
32. M. Han, A.W. Partin, and M. Zahurak Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer J Urol 169 2003 517 523
33. G.W. Hull, F. Rabbani, and F. Abbas Cancer control with radical prostatectomy alone in 1,000 consecutive patients J Urol 167 2002 528 534
34. G.M. Freedman, W.G. Negendank, and G.R. Hudes Preliminary results of a bone marrow magnetic resonance imaging protocol for patients with high-risk prostate cancer Urology 54 1999 118 123
35. M.A. Haider, T.H. van der Kwast, and J. Tanguay Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer AJR Am J Roentgenol 189 2007 323 328
36. Y. Mazaheri, H. Hricak, and S.W. Fine Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: Correlation with pathologic tumor volume Radiology 252 2009 449 457
37. B.N. Bloch, E. Furman-Haran, and T.H. Helbich Prostate cancer: Accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging - Initial results Radiology 245 2007 176 185
38. J.J. Fütterer, S.W. Heijmink, and T.W. Scheenen Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging Radiology 241 2006 449 458
39. J.J. Fütterer, M.R. Engelbrecht, and H.J. Huisman Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: Experienced versus less experienced readers Radiology 237 2005 541 549
40. J. Scheidler, H. Hricak, and D.B. Vigneron Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging - Clinicopathologic study Radiology 213 1999 473 480 (Pubitemid 29510595)